Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacira Pharmaceuticals buy Raymond James

Pacira Pharmaceuticals
Start price
€29.60
20.12.23 / 50%
Target price
€38.31
20.12.24
Performance (%)
-38.51%
End price
€18.20
21.12.24
Summary
This prediction ended on 21.12.24 with a price of €18.20. Massive losses of -38.51% were the result for the BUY prediction by Raymond_James. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pacira Pharmaceuticals 4.000% 4.000% -1.887%
iShares Core DAX® -1,59 % 5,03 % 6,33 %
iShares Nasdaq 100 -4,15 % -0,13 % 25,73 %
iShares Nikkei 225® -6,30 % 0,53 % 41,38 %
iShares S&P 500 -3,23 % 0,47 % 20,45 %

Comments by Raymond_James for this prediction

In the thread Pacira Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -38.51%
Target price 38.308
Change
Ends at 20.12.24

Pacira BioSciences, Inc. (NASDAQ: PCRX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $42.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat

Raymond James 
0
Report Share
20.12.23
In the thread Trading Pacira Pharmaceuticals
Prediction Buy
Perf. (%) -38.51%
Target price 38.308
Change
Ends at 20.12.24

Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

Raymond James 
0
Report Share
21.12.24

Stopped prediction by Raymond_James for Pacira Pharmaceuticals

buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€19.10
31.07.24
€34.20
31.07.25
-5.24%
01.08.25

Raymond James 
31.07.24 50%